What does the evidence actually say?
Most claims about cannabis and health are either wildly optimistic or dismissive. The research itself is more interesting — and more honest. Here's where the evidence stands for the conditions people most often ask about.
Research verdict cards
Ten conditions where people commonly use cannabis, with evidence levels graded the way the research actually reads them. Click any card for studies, caveats, and what the data doesn't yet tell us.
Evidence levels reflect the strength of published research, not a recommendation. Speak with your clinician before starting, stopping, or changing any medication — cannabis included.
Recent reporting
The cannabis cardiovascular problem: JAMA, JACC, and what the studies keep finding
JAMA Cardiology: endothelial dysfunction from smokers AND edible users, comparable to tobacco smokers. JACC: under-50 users 6.2x more likely to have a heart attack, 4.3x more likely to have a stroke. Meta-analysis: 2x cardiovascular death risk. The evidence is substantial, growing, and pointing in a consistent direction — and it deserves honest engagement, not dismissal.
Teen cannabis use keeps falling — even in legal states
Monitoring the Future — the federal government's 50-year running survey of American adolescent substance use — shows teen cannabis use down 23-45% since 2012, even as 26 states legalized adult-use. The 1999 peak predates any recreational legalization. The foundational prohibition argument that legalization would produce a teen use crisis has been empirically disconfirmed by the government's own data.
The runner's high is an endocannabinoid phenomenon, not an endorphin one — and it may explain why exercise helps anxiety
New research confirms that the euphoria of intense exercise is driven primarily by the body's own cannabinoid system, rewriting a decades-old assumption about endorphins.
New clinical data supports the entourage effect — terpenes significantly alter how THC affects the brain
A controlled trial at Johns Hopkins found that specific terpene profiles changed the subjective experience and neurological response to THC, lending scientific weight to a long-debated cannabis theory.
VA-backed study finds veterans using medical cannabis reduced opioid prescriptions by 47%
Published in JAMA Internal Medicine, the retrospective study of 15,000 veterans across 12 states found significant and sustained reductions in opioid use after medical cannabis enrollment.
Updated Cochrane review finds moderate evidence for cannabis in chronic pain, but significant gaps remain
The review analyzed 50 randomized controlled trials and found that cannabinoids may reduce chronic pain intensity by a small but meaningful amount — while flagging high rates of adverse events.
Largest-ever review finds no evidence cannabinoids effectively treat anxiety, depression, or PTSD
Published in The Lancet Psychiatry, the systematic review examined hundreds of studies and found insufficient evidence to support therapeutic claims for cannabinoid treatments of mental health conditions.